RBM6 mRNA was reported to be highly upregulated in many cancer types, such as breast cancer, malignant fibrous histiocytoma, ovary cystadenoma, non-Hodgkin’s lymphoma, and pancreatic cancer. Here, RBM6 is linked to non-Hodgkin lymphoma.